Abbott shares were down 3.9% in morning trading on mixed results for the heart-failure drug, levosimendan or Simdax, and another drug, Tricor, which was aimed at further reducing heart problems in diabetics on top of conventional therapy.
Abbott (nyse: ABT - news - people ) shares were down 3.9% in morning trading on mixed results for the heart-failure drug, levosimendan or Simdax, and another drug, Tricor, which was aimed at further reducing heart problems in diabetics on top of conventional therapy.
If he wants to scapegoat Congress and the Federal government for shorting cities on housing, Bloomberg has an immense repertoire to choose from: the flat out failure of foreclosure policies, anti-urban transportation funding, lending that stifles mixed-use developments, and so on.